Skip to main content
Top
Published in: Breast Cancer Research and Treatment 3/2006

01-08-2006 | Clinical trial

Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient’s perspective

Authors: Arti Hurria, Shari Goldfarb, Carol Rosen, Jimmie Holland, Enid Zuckerman, Mark S. Lachs, Matthew Witmer, Wilfred G. van Gorp, Monica Fornier, Gabriella D’Andrea, Mark Moasser, Chau Dang, Catherine Van Poznak, Mark Robson, Violante E. Currie, Maria Theodoulou, Larry Norton, Clifford Hudis

Published in: Breast Cancer Research and Treatment | Issue 3/2006

Login to get access
Metadata
Title
Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient’s perspective
Authors
Arti Hurria
Shari Goldfarb
Carol Rosen
Jimmie Holland
Enid Zuckerman
Mark S. Lachs
Matthew Witmer
Wilfred G. van Gorp
Monica Fornier
Gabriella D’Andrea
Mark Moasser
Chau Dang
Catherine Van Poznak
Mark Robson
Violante E. Currie
Maria Theodoulou
Larry Norton
Clifford Hudis
Publication date
01-08-2006
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2006
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-006-9171-6

Other articles of this Issue 3/2006

Breast Cancer Research and Treatment 3/2006 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine